Expand BMEA Menu
BMEA MENU

BMEA Latest Press Releases

-- March 31, 2026 --

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies Globe Newswire 7:00 AM

-- March 24, 2026 --

Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights Globe Newswire 4:05 PM

-- March 14, 2026 --

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 Globe Newswire 4:30 AM

-- February 19, 2026 --

Biomea Fusion to Participate at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- January 12, 2026 --

Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones Globe Newswire 8:00 AM

-- December 17, 2025 --

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- December 9, 2025 --

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 Globe Newswire 6:35 PM

-- December 5, 2025 --

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Globe Newswire 7:00 AM

-- December 1, 2025 --

Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Globe Newswire 4:10 PM
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 24, 2025 --

Biomea Fusion to Participate at Upcoming Investor Conferences Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes